Search

everythinglearnresearchcommunity

for

Search:↓

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Fat-derived stem cells may help treat skin aging and hair loss.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

The document concludes that careful planning, efficient use of every hair graft, and setting surgical priorities are crucial for successful hair restoration surgery.

The best results in surgical hair restoration come from careful techniques, optimal use of limited hair supply, correct hair direction, saving hair for key areas, understanding scarring effects, and adjusting hair graft density.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Fat-related cells are important for initiating hair growth.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Keratin 17 is crucial for early hair strength and cell survival.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

A gene deletion in DSG4 causes sparse hair in some Pakistani families.

Epidermal Growth Factor helps hair follicle cells grow and move by activating a specific cell signaling pathway.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

People with X-linked hypohidrotic ectodermal dysplasia have no sweat ducts and less, thinner hair.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Scientists can mimic hair disorders by altering genes in lab-grown human hair follicles, but these follicles lack some features of natural ones.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Lithium can cause skin issues like acne and hair loss.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.